Jeffrey T. L. Smith, Managing Director at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 24,322 shares at $17.81 ($434K) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Seasonal sale ($434k) by Managing Director — this insider has traded ALDR in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.81 | 11,061 | $197K | 45.4% |
| 2 | $17.81 | 11,061 | $197K | 45.4% |
| 3 | $18.29 | 1,100 | $20K | 4.6% |
| 4 | $18.29 | 1,100 | $20K | 4.6% |
| Total | $17.85 avg | 24,322 | $434K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |